Effective July 16, 2019, Alturas Analytics is thrilled to announce the appointment of Dr. Lori Payne to the Business Development team as Executive Director of Business Development joining Ann Hoffman, VP Strategic Development.
"Dr....
Chad has 20 years of related experience as an analytical scientist with over 15 focused on bioanalysis at Alturas Analytics. This depth of experience in applied LC-MS/MS and GC-MS/MS, along with an education in chemical engineering...
“Pharmacokinetic studies are a critical component in evaluating the safety and efficacy of a drug from discovery through post-marketing clinical trials.” Sara Underwood spent 16 years in the biotechnology industry performing...
The 58th Annual Meeting and ToxExpo
Society of Toxicology
March 10-14, Baltimore, MD
Baltimore Convention Center
We look forward to seeing you in Baltimore for a week of innovation and the impact that emerging technologies has...
A Message from Robin Woods, Alturas Analytics President
As the sun sets on a successful 2018, and we open 2019 feeling invigorated and are poised for another growth year at Alturas, we would like to thank our partners for your continued...
A Message From Robin Woods, President
At Alturas Analytics, 2016 was the year for building infrastructure and preparing for growth to meet new challenges. With investments in capital equipment, scientific staff, a facility expansion,...
